Evidence map›Paper›PMID 26935106›Full record

ArticleDisease models & mechanisms2016

Cardiomyocyte-specific conditional knockout of the histone chaperone HIRA in mice results in hypertrophy, sarcolemmal damage and focal replacement fibrosis.

Nicolas Valenzuela, Qiying Fan, Faisal Fa'ak, Benjamin Soibam, Harika Nagandla, Yu Liu, Robert J Schwartz, Bradley K McConnell, M David Stewart

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Nucleosome proteostasis and histone turnover.Frontiers in molecular biosciences · 2022
    Review
  5. Review
  6. Article
  7. Epigenetic Regulation of Myogenesis: Focus on the Histone Variants.International journal of molecular sciences · 2021
    Review
  8. Article
  9. Epigenetics in Cardiac Hypertrophy and Heart Failure.JACC. Basic to translational science · 2019
    Review
  10. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of ProteinArteriosclerosis, thrombosis, and vascular biology · 2019
    Review
  11. Review
  12. Article
  13. Article
  14. Chinese medical journal · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nicolas ValenzuelaDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Qiying FanDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
Faisal Fa'akDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
Benjamin SoibamDepartment of Computer Science and Engineering Technology, University of Houston-Downtown, Houston, TX 77002, USA.
Harika NagandlaDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Yu LiuDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Robert J SchwartzDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA Stem Cell Engineering Department, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, TX 77030, USA.
Bradley K McConnellDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
M David StewartDepartment of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA dstewart@uh.edu.
University of Houston · USUniversity of Houston - Downtown · US

Funding

Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac ContractilitR01HL085487 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI MCCONNELL, BRADLEY K · 2007 to 2011
$2.3M
Scaffolding Protein Interaction Network Regulates Cardiac Cell SignalingR15HL124458 · NHLBI · UNIVERSITY OF HOUSTON · PI MCCONNELL, BRADLEY K · 2015 to 2015
$452k
NHLBI NIH HHS R01 HL085487NHLBI NIH HHS R15 HL124458
6 · The paper itself

Abstract

HIRA is the histone chaperone responsible for replication-independent incorporation of histone variant H3.3 within gene bodies and regulatory regions of actively transcribed genes, and within the bivalent promoter regions of developmentally regulated genes. The HIRA gene lies within the 22q11.2 deletion syndrome critical region; individuals with this syndrome have multiple congenital heart defects. Because terminally differentiated cardiomyocytes have exited the cell cycle, histone variants should be utilized for the bulk of chromatin remodeling. Thus, HIRA is likely to play an important role in epigenetically defining the cardiac gene expression program. In this study, we determined the consequence of HIRA deficiency in cardiomyocytes in vivo by studying the phenotype of cardiomyocyte-specific Hira conditional-knockout mice. Loss of HIRA did not perturb heart development, but instead resulted in cardiomyocyte hypertrophy and susceptibility to sarcolemmal damage. Cardiomyocyte degeneration gave way to focal replacement fibrosis and impaired cardiac function. Gene expression was widely altered in Hira conditional-knockout hearts. Significantly affected pathways included responses to cellular stress, DNA repair and transcription. Consistent with heart failure, fetal cardiac genes were re-expressed in the Hira conditional knockout. Our results suggest that transcriptional regulation by HIRA is crucial for cardiomyocyte homeostasis.

Indexed as

AnimalsApoptosisCardiomegalyCell Cycle ProteinsCell ProliferationDNA DamageDNA RepairFetusGene Expression RegulationHeart Function TestsHistone ChaperonesMice, KnockoutMyocytes, CardiacOrgan SpecificityOxidative StressReproducibility of ResultsCell Cycle ProteinsHira protein, mouseHistone ChaperonesTranscription FactorsCardiomyocyteH3.3HeartHIRAHistone

Identifiers

PMID26935106
PMCPMC4833330
OpenAlexW2292591922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.